Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 289,557	$ 409,039
Accounts receivable	12,578
Inventory	4,071	4,131
Prepaid expense and other current assets	25,658	32,124
Total current assets	331,864	445,294
Patents, net	143,130	146,263
Property and equipment, net	4,486	5,069
Total assets	479,480	596,626
Liabilities and Stockholders' Equity (Deficit)
Accounts payable and accrued expenses	300,393	208,727
Advances from investors	100,000	100,000
Convertible notes payable – related party	512,464	444,581
Total current liabilities	912,857	753,308
Total liabilities	912,857	753,308
Stockholders' equity (deficit)
Preferred stock, $0.01 par value: Authorized shares - 10,000,000, Issued and outstanding shares – 0 at March 31, 2020 and December 31, 2019
Common stock, $0.01 par value: Authorized shares - 100,000,000, Issued and outstanding shares –40,516,351 and 40,516,351 at March 31, 2020 and December 31, 2019, respectively	405,164	405,164
Additional paid-in capital	4,307,970	4,207,786
Accumulated deficit	(5,146,511)	(4,769,632)
Total stockholders’ equity (deficit)	(433,377)	(156,682)
Total liabilities and stockholders’ equity (deficit)	$ 479,480	$ 596,626